HER2 Support Group Forums - View Single Post - BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal wo

News · 09-12-2011, 06:50 AM

BioSante Pharmaceuticals, Inc., today announced successful completion of its principal LibiGel (testosterone gel) pharmacokinetic (PK) study.

More...

09-12-2011, 06:50 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,123	BioSante reports top-line results from LibiGel PK study for HSDD in postmenopausal wo BioSante Pharmaceuticals, Inc., today announced successful completion of its principal LibiGel (testosterone gel) pharmacokinetic (PK) study. More...